Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05761574 · ClinicalTrials.gov registry record · Phase 3
A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain
A Phase 3 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 447
- Enrollment target
NCT05761574 is a Phase 3 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 447 participants.
The verdict
NCT05761574, a Phase 3 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 447 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how well a fixed combination of acetaminophen/naproxen sodium relieves postoperative dental pain compared with acetaminophen, naproxen sodium and placebo.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Naproxen Sodium
- DRUG Acetaminophen/Naproxen Sodium Fixed Combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05761574
The ClinicalTrials.gov registry entry for NCT05761574 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT05761574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05761574 about?
NCT05761574 is a clinical study titled "A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain". The purpose of this study is to evaluate how well a fixed combination of acetaminophen/naproxen sodium relieves postoperative dental pain compared with acetaminophen, naproxen sodium and placebo.
What is the current status of trial NCT05761574?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 447 participants. The study started on 2023-05-22. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT05761574?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Naproxen Sodium (DRUG), Acetaminophen/Naproxen Sodium Fixed Combination (DRUG).
Who is sponsoring clinical trial NCT05761574?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.